Headquartered in Brea, CA Fiscal year ends December NYSE: NVST envistaco.com
Envista Holdings Corporation is a global dental products company that unites more than 30 brands, including DEXIS, Kerr, Nobel Biocare, Ormco and Spark. It provides dental professionals with a portfolio of technologies, consumables and services.
The company reports two segments:
- Specialty Products & Technologies: includes dental implants (Nobel Biocare), traditional and digital orthodontics including clear aligners (Ormco, Spark), and related specialty products.
- Equipment & Consumables: includes 2D, 3D and intraoral imaging equipment (DEXIS) and dental consumables (Kerr).
Envista operates under the Envista Business System, a continuous-improvement framework used to drive margin expansion. It is pursuing legal entity simplification, share repurchases and bolt-on acquisitions. Updated
Five straight quarters of beating consensus EPS, and management raised full-year adjusted EPS guidance again to $1.54 to $1.58. Adjusted operating margin widened to 13.7%, with the earnings leverage coming from cost execution. Keep an eye on the stock after hours.
Markets wobble heading into the Labor Day weekend as bond vigilantes push back against Washington, oil stays tense with Middle East strikes escalating, and Wall Street analysts make bold calls on names…
John Rogers built his fortune hunting unloved stocks that the market abandoned too soon, but three of his favorite contrarian bets look very different when filtered through the lens of retirement income…
With consumer sentiment sitting at 53.3 in March 2026, deep in pessimistic territory, retail investors are hunting for defensive names that can grow even as households tighten budgets. Healthcare keeps that promise.…
Wednesday's top analyst upgrades and downgrades included Bluebird Bio, Boeing, Coinbase Global, Costco Wholesale, Envista, Merck, New Fortress Energy, NexTier Oilfield Solutions, Radius Global Infrastructures, Regions Financial and Wayfair.
Envista Holdings Corporation is a global dental products company that unites more than 30 brands, including DEXIS, Kerr, Nobel Biocare, Ormco and Spark. It provides dental professionals with a portfolio of technologies, consumables and services.
24/7 Wall St.'s 12-month price target for NVST is $33.81, rated Buy. The Wall Street consensus target is $28.92. NVST price prediction →
